Skip to main content

BD Biosciences, Scanalytics Partner on Automated Image Analysis for High-Content Screening

LONDON, June 17 (GenomeWeb News) -- BD Biosciences has entered into a "strategic partnership" with informatics firm Scanalytics to develop image analysis software for BD Bioscience's automated microscopy platforms, a company representative said here yesterday at the Marcus Evans High-Content Screening conference.

 

According to Dietrich Ruehlmann, BD Biosciences' product manager for imaging and analysis, BD began the partnership with Scanalytics a few months ago with the goal of developing image analysis platforms for BD Biosciences' CARV II Confocal Imager and Pathway Bioimager for high-content drug screening.

 

Scanalytics, based in Fairfax, Va., markets scientific imaging software, including deconvolution and 3D restoration and gel analysis software.

 

A development timeline for the image analysis software was not provided.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.